American Healthcare REIT, Inc. (AHR)
Official siteREAL ESTATE • REIT - HEALTHCARE FACILITIES • NYSE
Market Cap: $13.48B
Last updated: Nov 17, 2026 at 4:15 PM ET
American Healthcare REIT, Inc. (AHR) Statistics
American Healthcare REIT (AHR) has a market cap of $13.48B and a P/FFO of 22.6x on its 2026 FFO estimate. Its share count is up 33.64% from a year earlier. Revenue grew 21.49% over the last 12 months from the 12 months before.
Total Valuation
Enterprise value is 8.62% above the market cap, as debt exceeds cash.
| Market Cap | $13.48B |
|---|---|
| Enterprise Value | $14.64B |
| Latest price (Nov 17, 2026) | $57.95 |
Key Dates
The next earnings report is expected on Feb 22, 2027, covering the quarter ending Dec 31, 2026. The last ex-dividend date was Sep 30, 2026.
| Next Earnings Date | Feb 22, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 5, 2026 |
| Last Ex-Dividend Date | Sep 30, 2026 |
| Last Payment Date | Oct 16, 2026 |
| Fiscal Year End | December |
Valuation Ratios
P/FFO is 22.6x on the 2026 FFO estimate of $2.56 a share.
| P/FFO (2026 estimate) | 22.6x |
|---|---|
| Forward P/E | 94.3x |
| P/S Ratio | 4.7x |
| Forward P/S | 4.8x |
| P/B Ratio | 2.3x |
| P/TBV Ratio | 2.6x |
| P/FCF Ratio | 62.7x |
| P/OCF Ratio | 32.0x |
Enterprise Valuation
Counting debt and cash, the company is valued at 28.6x EBITDA and 68.5x free cash flow.
| EV / Earnings | 152.0x |
|---|---|
| EV / Sales | 5.5x |
| EV / EBITDA | 28.6x |
| EV / EBIT | 86.0x |
| EV / FCF | 68.5x |
Price Statistics
The stock is up 21.78% over 52 weeks and trades 8.44% above its 50-day average.
| Beta (1Y) | 0.05 |
|---|---|
| 52-Week Change | +21.78% |
| 1-Month Change | +10.48% |
| 3-Month Change | +5.48% |
| 6-Month Change | +15.15% |
| Total Return (1Y) | +23.88% |
| Return vs SPY (1Y) | +8.14% |
| Max Drawdown (1Y) | -14.05% |
| Max Drawdown (3Y) | -14.05% |
| Sharpe Ratio (1Y) | 0.69 |
| Correlation with SPY (1Y) | 0.03 |
| 50-Day Average | $53.44 |
| 200-Day Average | $51.79 |
| 52-Week Range | $44.36 to $59.55 |
| RSI (14 Days) | 62.9 |
| Average Volume (20 Days) | 3.36M |
Financial Position
Current assets cover 0.24x current liabilities, and total debt is 0.25x shareholder equity.
| Current Ratio | 0.24x |
|---|---|
| Quick Ratio | 0.22x |
| Debt / Equity | 0.25x |
| Debt / EBITDA | 2.87x |
| Debt / FCF | 6.88x |
| Interest Coverage | 2.27x |
Returns and Efficiency
Return on invested capital is 2.46% over the last 12 months, against a 5-year average of 1.41%.
| Return on Equity (ROE) | 1.74% |
|---|---|
| Return on Assets (ROA) | 1.27% |
| Return on Invested Capital (ROIC) | 2.46% |
| Return on Capital Employed (ROCE) | 2.55% |
| ROE (5Y Average) | -2.81% |
| ROA (5Y Average) | -0.77% |
| ROIC (5Y Average) | 1.41% |
| Asset Turnover | 0.43x |
| Inventory Turnover | 107.55x |
| Receivables Turnover | 11.66x |
Scores
AHR has a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 6 of 9 |
|---|---|
| Piotroski Strength | Average |
Income Statement
FFO per share was $2.19 for 2025, the latest reported year. Revenue was $2.67B over the last 12 months.
| FFO Per Share (2025) | $2.19 |
|---|---|
| Revenue | $2.67B |
| Revenue Growth (YoY) | +21.49% |
| Gross Profit | $420.17M |
| Operating Income | $173.38M |
| Pretax Income | $95.24M |
| Net Income | $96.31M |
| EBITDA | $482.47M |
| EBIT | $170.24M |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 72.80% of the $7.61B in total assets.
| Cash and Equivalents | $222.77M |
|---|---|
| Total Debt | $1.38B |
| Net Debt | $1.16B |
| Net Debt Per Share | $5.33 |
| Working Capital | -$699.28M |
| Shareholder Equity | $5.54B |
| Book Value Per Share | $25.43 |
| Tangible Book Value | $4.93B |
| Tangible Book Per Share | $22.65 |
| Total Assets | $7.61B |
| Total Liabilities | $1.96B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $220.63M of capital spending, operating cash flow left $201.12M of free cash flow.
| Operating Cash Flow | $421.74M |
|---|---|
| Capital Expenditures | $220.63M |
| Free Cash Flow | $201.12M |
| FCF Per Share | $0.87 |
| Depreciation and Amortization | $303.30M |
| Dividends Paid | $186.07M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 6.49%, against a 5-year average of 6.96%.
| Gross Margin | 15.73% |
|---|---|
| Operating Margin | 6.49% |
| Pretax Margin | 3.57% |
| Net Margin | 3.61% |
| EBITDA Margin | 18.06% |
| EBIT Margin | 6.37% |
| FCF Margin | 7.53% |
| Gross Margin (5Y Average) | 19.03% |
| Operating Margin (5Y Average) | 6.96% |
| Net Margin (5Y Average) | -2.28% |
Growth
Revenue grew 11.80% a year over 3 years.
| Revenue Growth (3Y CAGR) | +11.80% |
|---|---|
| Revenue Growth (5Y CAGR) | +13.79% |
| FCF Growth (3Y CAGR) | +29.57% |
| FCF Growth (5Y CAGR) | +12.79% |
| Operating Income Growth (3Y CAGR) | +23.07% |
| Book Value Per Share Growth (2Y CAGR) | +1.72% |
| Tangible Book Per Share Growth (2Y CAGR) | +14.52% |
Dividends and Yields
AHR pays out 45.66% of 2025 FFO as dividends.
| Dividend Per Share (Annual) | $1.00 |
|---|---|
| Dividend Yield | 1.73% |
| Payment Schedule | Quarterly |
| Payout Ratio (2025 FFO) | 45.66% |
| FCF Payout Ratio | 92.52% |
| FFO Yield (2025) | 3.78% |
| FCF Yield | 1.59% |
| Shareholder Yield | 1.47% |
Peer Position
Against 12 similar companies, AHR has the 2nd highest P/FFO and the 10th highest P/S.
P/FFOPeer median 11.7x
P/S RatioPeer median 5.7x
ROICPeer median 2.74%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +20.76%
Dividend YieldPeer median 5.72%
| P/FFO | 22.6x vs 11.7x median |
|---|---|
| P/S Ratio | 4.7x vs 5.7x median |
| ROIC | 2.46% vs 2.74% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +21.49% vs +20.76% median |
| Dividend Yield | 1.73% vs 5.72% median |
Analyst Forecast
FFO per share estimates imply 14.08% growth a year over the next 2 years.
| FFO Per Share Growth Forecast (2Y CAGR) | +14.08% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About AHR
What is AHR's market cap?
American Healthcare REIT has a market cap of $13.48B. Its enterprise value, which adds debt and subtracts cash, is $14.64B.
What is AHR's price to FFO ratio?
American Healthcare REIT has a P/FFO of 22.6x on its 2026 FFO estimate.
How many shares of AHR are outstanding?
American Healthcare REIT has 217.71M shares outstanding. The count is up 33.64% from a year earlier.
Does AHR pay a dividend?
Yes. American Healthcare REIT pays $1.00 a share a year, a dividend yield of 1.73%.
How much debt does AHR have?
American Healthcare REIT has $1.38B of total debt and $222.77M of cash and equivalents, a net debt position of $1.16B.
AHR pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors